Jerrold Grossman Biography and Net Worth

Director of ADMA Biologics


Dr. Grossman has been a director of the Company since 2007, is the Vice Chairman of our Board and is a co-founder of the Company. Dr. Grossman has over 35 years of experience in the blood and plasma industry. He served as the Chief Executive Officer of ADMA, on a part-time basis, between 2007 and October 2011. He is the founder and Chief Executive Officer of Technomed, Inc. (formerly National Hospital Specialties), a wholesaler of specialty biological and pharmaceutical products, and has served as Chief Executive Officer of that company since 1980. Additionally, Dr. Grossman is the founder and President of GenesisBPS, a medical device firm specializing in blood collection and processing equipment, and has served as President of that company since 1990. Previously, he held positions at the New York Blood Center and Immuno-U.S., Inc. and previously served as the Chairman of the Board of Bergen Community Blood Services. Currently, Dr. Grossman is a member of the New Jersey Blood Bank Task Force and a founder and director of the New Jersey Association of Blood Bank Professionals. He was a founder and former director of Pascack Bancorp, Inc., which was acquired by Lakeland Bancorp, Inc. in January 2016, and is currently a member of the Corporate Advisory Council of Lakeland Bancorp Inc. Dr. Grossman has also provided consulting services to various government agencies and international organizations. He received a B.A. in Economics and Finance from Fairleigh Dickinson University, an M.B.A. from Fairleigh Dickinson University, and his D.P.S. in Business Management from Pace University. Dr. Grossman is the father of Adam S. Grossman, our President, Chief Executive Officer and Interim Chief Financial Officer. He was chosen to serve on the Board because of his role as our co-founder and past Chief Executive Officer, as well as his more than 35 years of experience serving a variety of companies and associations in the blood and plasma industry.

What is Jerrold B. Grossman's net worth?

The estimated net worth of Jerrold B. Grossman is at least $9.34 million as of August 29th, 2024. Dr. Grossman owns 467,305 shares of ADMA Biologics stock worth more than $9,336,754 as of September 22nd. This net worth estimate does not reflect any other assets that Dr. Grossman may own. Additionally, Dr. Grossman receives an annual salary of $90,000.00 as Director at ADMA Biologics. Learn More about Jerrold B. Grossman's net worth.

How old is Jerrold B. Grossman?

Dr. Grossman is currently 76 years old. There are 1 older executives and no younger executives at ADMA Biologics. Learn More on Jerrold B. Grossman's age.

What is Jerrold B. Grossman's salary?

As the Director of ADMA Biologics, Inc., Dr. Grossman earns $90,000.00 per year. The highest earning executive at ADMA Biologics is Mr. Adam S. Grossman, Co-Founder, President, CEO, Interim CFO & Director, who commands a salary of $1,590,000.00 per year. Learn More on Jerrold B. Grossman's salary.

How do I contact Jerrold B. Grossman?

The corporate mailing address for Dr. Grossman and other ADMA Biologics executives is 465 STATE ROUTE 17, RAMSEY NJ, 07446. ADMA Biologics can also be reached via phone at (201) 478-5552 and via email at [email protected]. Learn More on Jerrold B. Grossman's contact information.

Has Jerrold B. Grossman been buying or selling shares of ADMA Biologics?

During the last ninety days, Jerrold B. Grossman has sold $2,363,589.47 in ADMA Biologics stock. Most recently, Jerrold B. Grossman sold 136,861 shares of the business's stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $17.27, for a transaction totalling $2,363,589.47. Following the completion of the sale, the director now directly owns 467,305 shares of the company's stock, valued at $8,070,357.35. Learn More on Jerrold B. Grossman's trading history.

Who are ADMA Biologics' active insiders?

ADMA Biologics' insider roster includes Steve Elms (Director), Bryant Fong (Director), Adam Grossman (CEO), Jerrold Grossman (Director), Lawrence Guiheen (Director), Young Kwon (Director), and Brian Lenz (CFO). Learn More on ADMA Biologics' active insiders.

Are insiders buying or selling shares of ADMA Biologics?

During the last year, insiders at the biotechnology company sold shares 9 times. They sold a total of 1,206,795 shares worth more than $13,223,289.83. The most recent insider tranaction occured on September, 9th when Director Lawrence P Guiheen sold 9,000 shares worth more than $166,230.00. Insiders at ADMA Biologics own 3.7% of the company. Learn More about insider trades at ADMA Biologics.

Information on this page was last updated on 9/9/2024.

Jerrold B. Grossman Insider Trading History at ADMA Biologics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/29/2024Sell136,861$17.27$2,363,589.47467,305View SEC Filing Icon  
8/30/2023Buy130,000$3.71$482,300.00443,265View SEC Filing Icon  
9/10/2020Buy5,000$2.22$11,100.00View SEC Filing Icon  
9/10/2020Buy5,000$2.22$11,100.00View SEC Filing Icon  
8/21/2020Buy5,300$2.56$13,568.00View SEC Filing Icon  
8/12/2020Buy10,200$2.89$29,478.00View SEC Filing Icon  
6/8/2018Buy20,921$4.78$100,002.3898,007View SEC Filing Icon  
5/3/2016Buy45,769$6.50$297,498.50View SEC Filing Icon  
12/7/2015Buy500$9.01$4,505.0056,558View SEC Filing Icon  
12/2/2015Buy6,000$9.16$54,960.0056,058View SEC Filing Icon  
3/17/2015Buy500$8.01$4,005.00View SEC Filing Icon  
12/10/2013Buy3,650$7.30$26,645.00View SEC Filing Icon  
See Full Table

Jerrold B. Grossman Buying and Selling Activity at ADMA Biologics

This chart shows Jerrold B Grossman's buying and selling at ADMA Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ADMA Biologics Company Overview

ADMA Biologics logo
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Read More

Today's Range

Now: $19.98
Low: $19.43
High: $20.16

50 Day Range

MA: $15.77
Low: $11.30
High: $19.98

2 Week Range

Now: $19.98
Low: $3.06
High: $20.16

Volume

45,181,979 shs

Average Volume

3,430,743 shs

Market Capitalization

$4.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61